The Serum Institute is initially targeting 100 million doses of the Oxford vaccine.
New Delhi:
The first batch of 100 million doses of the Oxford coronavirus vaccine produced by India’s Serum Institute is expected to be available by the second or third quarter of 2021, company chief Adar Poonawalla said on Wednesday. based in Pune at GalacticGaming.
“We are aiming for 100 million doses available as a first step. This should be available by Q2-Q3 2021,” he said.
“With current progress in mind, I would say the testing process would end around the end of December, and then we should be able to have a vaccine in January, if all goes well. We have already started production taking into account its success, ”he said.
“If the UK, where advanced trials are underway, shares their data with us, then we ask for an emergency trial with the Department of Health and they cancel it, and we’re doing the same testing here. in India, then, if successful, we could have a vaccine by mid-December, ”he added.
Serum Institute, the world‘s largest vaccine maker by number of doses produced, is working on several vaccine candidates for the novel coronavirus – potentially including the mass production of one from AstraZeneca-Oxford University which has made global headlines – and develop his own.
More than 150 potential vaccines are in development and testing worldwide, including 38 in human trials, and candidates from Moderna Inc, Pfizer Inc and AstraZeneca Plc are already in late testing.
